| 000 | 01765 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516150304.0 | ||
| 264 | 0 | _c20140901 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1399-3003 | ||
| 024 | 7 |
_a10.1183/09031936.00199312 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHostettler, Katrin E | |
| 245 | 0 | 0 |
_aCalcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation. _h[electronic resource] |
| 260 |
_bThe European respiratory journal _cJan 2014 |
||
| 300 |
_a221-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBronchiolitis Obliterans _xdrug therapy |
| 650 | 0 | 4 | _aCalcineurin Inhibitors |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForced Expiratory Volume |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aLung _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xpharmacology |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMyofibroblasts _xdrug effects |
| 650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacology |
| 700 | 1 | _aHalter, Jörg P | |
| 700 | 1 | _aGerull, Sabine | |
| 700 | 1 | _aLardinois, Didier | |
| 700 | 1 | _aSavic, Spasenija | |
| 700 | 1 | _aRoth, Michael | |
| 700 | 1 | _aTamm, Michael | |
| 773 | 0 |
_tThe European respiratory journal _gvol. 43 _gno. 1 _gp. 221-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1183/09031936.00199312 _zAvailable from publisher's website |
| 999 |
_c22725535 _d22725535 |
||